annb0t
Top 20
The Chemours Company CC is benefiting from continued adoption of its Opteon refrigerants, strong execution, higher pricing and cost-cutting measures. However, slow demand recovery may impact its performance.
The companyâs shares are down 36.3% over a year, compared with 11% decline recorded by its industry. Zacks Investment Research
Image Source: Zacks Investment Research
Higher Opteon Demand and Cost Actions Aid Chemours
Chemours is gaining from strong execution and its cost-reductio...
>>> Read more: Here's Why You Should Hold Onto Chemours (CC) Stock for Now
The companyâs shares are down 36.3% over a year, compared with 11% decline recorded by its industry. Zacks Investment Research
Image Source: Zacks Investment Research
Higher Opteon Demand and Cost Actions Aid Chemours
Chemours is gaining from strong execution and its cost-reductio...
>>> Read more: Here's Why You Should Hold Onto Chemours (CC) Stock for Now
